To amend the Internal Revenue Code of 1986 to provide for a credit against tax for expenses for translational research regarding neurodegenerative diseases and psychiatric conditions.

3/22/2025, 8:06 AM

Summary of Bill HR 2085

Bill 119 HR 2085, also known as the Translational Research for Neurodegenerative Diseases and Psychiatric Conditions Act, aims to amend the Internal Revenue Code of 1986 to offer a tax credit for expenses related to translational research in the field of neurodegenerative diseases and psychiatric conditions.

The bill seeks to incentivize and support research efforts focused on finding treatments and cures for diseases such as Alzheimer's, Parkinson's, and mental health conditions like depression and schizophrenia. By providing a tax credit for qualifying expenses incurred during translational research, the legislation aims to encourage more investment and innovation in these critical areas of healthcare.

Overall, Bill 119 HR 2085 aims to promote advancements in the understanding and treatment of neurodegenerative diseases and psychiatric conditions by providing financial support to researchers and organizations engaged in translational research. This bipartisan effort underscores the importance of addressing these pressing health challenges and underscores the role of government in supporting scientific progress and innovation in the medical field.

Current Status of Bill HR 2085

Bill HR 2085 is currently in the status of Bill Introduced since March 11, 2025. Bill HR 2085 was introduced during Congress 119 and was introduced to the House on March 11, 2025. Bill HR 2085's most recent activity was Referred to the House Committee on Ways and Means. as of March 11, 2025

Bipartisan Support of Bill HR 2085

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 2085

Primary Policy Focus

Alternate Title(s) of Bill HR 2085

To amend the Internal Revenue Code of 1986 to provide for a credit against tax for expenses for translational research regarding neurodegenerative diseases and psychiatric conditions.To amend the Internal Revenue Code of 1986 to provide for a credit against tax for expenses for translational research regarding neurodegenerative diseases and psychiatric conditions.

Start holding our government accountable!